BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UM//UM*Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Detroit
TZURL:http://tzurl.org/zoneinfo/America/Detroit
X-LIC-LOCATION:America/Detroit
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20070311T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20071104T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20250926T155855
DTSTART;TZID=America/Detroit:20251003T100000
DTEND;TZID=America/Detroit:20251003T112000
SUMMARY:Workshop / Seminar:To Sell or For Sale: Strategic Entry in Pharmaceutical Markets (joint with Zoey Chopra and Garth Strohbehn)
DESCRIPTION:Increasing consolidation in the pharmaceutical industry has prompted antitrust concerns and calls for enhanced scrutiny and regulation surrounding M&A activity\, particularly regarding acquisitions of small and innovative biotechs. Holding firm entry fixed\, such policy should encourage competition and limit the ability of incumbent firms to acquire early-stage competitors. In resource-intensive industries such as pharmaceuticals\, however\, firms make entry decisions conditional upon eventual exit strategies. Limitations to M&A activity may reduce incentives for biotech entry\, ultimately resulting in less innovation and welfare losses. Leveraging M&A and drug development data in oncology from 2006 to 2019 we document three facts: 1. Big pharmaceutical firms constitute the majority of controlling interest acquisitions\; 2. The probability of acquisition is strongly associated with the entry choice of small biotech drugs but there is no association for big pharmaceutical drugs\; and 3. The acquisition price for a drug increases when the acquiring firm has an overlapping development pipeline. These insights inform a structural model in which acquisitions are the result of a first-price sealed bid auction that informs a static firm entry and market choice decision for new drugs. We find that a counterfactual which restricts the ability of big pharma firms to acquire overlapping biotech drugs significantly changes the market choice of biotech drugs\, but we do not find a significant change in overall biotech drug entry\, suggesting such a policy would have minimal welfare costs.
UID:139949-21886396@events.umich.edu
URL:https://events.umich.edu/event/139949
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:seminar,Industrial Organization,Economics
LOCATION:Lorch Hall - 301
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20250911T102149
DTSTART;TZID=America/Detroit:20251003T100000
DTEND;TZID=America/Detroit:20251003T113000
SUMMARY:Workshop / Seminar:Welcome to Washtenaw County: Beyond the Data
DESCRIPTION:Do you do research or teaching in partnership with communities? Would you like to find ways to connect your work at U-M with local communities?  With a network of over 400 community partners across Washtenaw County and Southeast Michigan\, Ginsberg Center works to connect local communities with U-M courses\, researchers\, internships and other community-engaged initiatives. In this workshop\, we’ll take you beyond the data to help you understand local priorities and university-community dynamics in Washtenaw County. You’ll leave with an understanding of key issues facing our local community and answers to your questions about what local communities really want from U-M stakeholders. \n\nWith special guest\, Ginsberg Center Community Leader-in-Residence Jessica A.S. Letaw \n\nJessica A.S. Letaw (she/her) is a housing justice organizer whose work bridges policy\, organizing\, and racial justice. She has been deeply involved in land use and zoning reform efforts\, housing affordability initiatives\, and neighborhood-based organizing. With a background in architecture and public engagement\, Jess combines technical knowledge of the built environment with questions around equity\, belonging\, and access. She is co-founder of FutureRoot\, a woman-led collective working at the intersections of race\, place\, history and culture. She is also the co-founder of the Co-liberation Collaborative\, working alongside white women and femmes to reimagine the role of white folks in political campaigns and movements\; founded Ann Arbor Housing for All\; and is the co-host of the local policy and politics podcast Ann Arbor AF. Her forthcoming book\, MOVE\, is a primer on housing organization for anyone. \n\nOpen to U-M faculty\, graduate students/GSIs\, post-docs\, admin/staff. \n\nRegsiter Here: https://sessions.studentlife.umich.edu/track/event/session/97059
UID:137443-21880245@events.umich.edu
URL:https://events.umich.edu/event/137443
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Postdoctoral Research Fellows,Staff,Sessions,Faculty,Graduate Students
LOCATION:Off Campus Location
CONTACT:
END:VEVENT
END:VCALENDAR